Holen Sie sich die Stockscreener-App
2.89
4.33%
0.12
Handel nachbörslich:
2.89
Schlusskurs vom Vortag:
$2.77
Offen:
$2.815
24-Stunden-Volumen:
2,759
Relative Volume:
0.42
Marktkapitalisierung:
$4.32M
Einnahmen:
$2.54M
Nettoeinkommen (Verlust:
$-4.13M
KGV:
-1.0509
EPS:
-2.75
Netto-Cashflow:
$-4.11M
1W Leistung:
+3.21%
1M Leistung:
+17.24%
6M Leistung:
-23.65%
1J Leistung:
-32.32%
1-Tages-Spanne:
$2.78
$2.89
1-Wochen-Bereich:
$2.6612
$2.9218
52-Wochen-Spanne:
$2.20
$5.20
Xenetic Biosciences Inc Stock (XBIO) Company Profile
Firmenname
Xenetic Biosciences Inc
Sektor
Branche
Telefon
781-778-7720
Adresse
945 CONCORD ST., FRAMINGHAM, MA
Vergleichen Sie XBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIO
Xenetic Biosciences Inc
|
2.89 | 4.32M | 2.54M | -4.13M | -4.11M | -2.75 |
|
VRTX
Vertex Pharmaceuticals Inc
|
500.19 | 127.64B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
603.58 | 65.95B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
656.65 | 37.92B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
273.55 | 32.98B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
254.16 | 26.92B | 3.81B | -644.79M | -669.77M | -6.24 |
Xenetic Biosciences Inc Stock (XBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-01-08 | Eingeleitet | Maxim Group | Buy |
Xenetic Biosciences Inc Aktie (XBIO) Neueste Nachrichten
Xenetic Biosciences Inc expected to post a loss of 72 cents a shareEarnings Preview - TradingView
Xenetic Biosciences, Inc. Announces Executive Leadership Transition - ACCESS Newswire
Press Release Distribution & PR Platform - ACCESS Newswire
Xenetic Biosciences (XBIO) to Release Earnings on Thursday - Defense World
Xenetic Biosciences, Inc. Reports 2018 Year End Results and Provides Corporate Update - ACCESS Newswire
Xenetic Biosciences, Inc. Reports First Quarter 2021 Financial Results - ACCESS Newswire
Xenetic Biosciences, Inc. Appoints Accomplished Biopharmaceutical Executive, Greg MacMichael, Ph.D. to Scientific Advisory Board - ACCESS Newswire
Xenetic Biosciences, Inc. Receives Approval to Commence Exploratory Study of XCART(TM) - ACCESS Newswire
Xenetic Biosciences Inc (NASDAQ:XBIO) Short Interest Update - Defense World
Analyzing Ampio Pharmaceuticals (NYSE:AMPE) & Xenetic Biosciences (NASDAQ:XBIO) - Defense World
Xenetic Biosciences (NASDAQ:XBIO) Earns Neutral Rating from HC Wainwright - Defense World
Xenetic Biosciences appoints new accounting firm By Investing.com - Investing.com Canada
Xenetic Biosciences appoints new accounting firm - Investing.com
Wainwright maintains Neutral on Xenetic shares after segment - Investing.com
Wainwright maintains Neutral on Xenetic shares after segment By Investing.com - Investing.com South Africa
Xenetic Biosciences, Inc. Releases Virtual Investor "What This M - GuruFocus
Xenetic Biosciences, Inc. Releases Virtual Investor "What This Means" Segment - guardonline.com
Finanzdaten der Xenetic Biosciences Inc-Aktie (XBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
3.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):